STERIS plc (NYSE:STE) Shares Sold by Lord Abbett & CO. LLC

Lord Abbett & CO. LLC cut its stake in STERIS plc (NYSE:STE) by 47.2% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 77,593 shares of the medical equipment provider’s stock after selling 69,470 shares during the period. Lord Abbett & CO. LLC owned approximately 0.08% of STERIS worth $18,819,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of STE. West Coast Financial LLC boosted its holdings in shares of STERIS by 2.8% in the 3rd quarter. West Coast Financial LLC now owns 1,640 shares of the medical equipment provider’s stock valued at $398,000 after purchasing an additional 45 shares during the last quarter. Taylor Frigon Capital Management LLC raised its position in shares of STERIS by 0.8% in the 2nd quarter. Taylor Frigon Capital Management LLC now owns 6,175 shares of the medical equipment provider’s stock worth $1,356,000 after buying an additional 46 shares during the period. SkyView Investment Advisors LLC boosted its holdings in STERIS by 1.6% in the third quarter. SkyView Investment Advisors LLC now owns 3,153 shares of the medical equipment provider’s stock valued at $765,000 after acquiring an additional 51 shares during the last quarter. Waterloo Capital L.P. grew its position in STERIS by 3.2% during the second quarter. Waterloo Capital L.P. now owns 1,916 shares of the medical equipment provider’s stock valued at $421,000 after acquiring an additional 59 shares during the period. Finally, Bailard Inc. increased its stake in STERIS by 6.4% during the second quarter. Bailard Inc. now owns 1,150 shares of the medical equipment provider’s stock worth $252,000 after acquiring an additional 69 shares during the last quarter. 94.69% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. Stephens reaffirmed an “overweight” rating and issued a $260.00 price objective on shares of STERIS in a research note on Thursday, November 7th. JMP Securities reaffirmed a “market outperform” rating and set a $265.00 price target on shares of STERIS in a research report on Monday, November 18th. Needham & Company LLC reissued a “hold” rating on shares of STERIS in a research report on Friday, November 8th. StockNews.com lowered shares of STERIS from a “strong-buy” rating to a “buy” rating in a report on Tuesday, October 29th. Finally, KeyCorp upped their price target on shares of STERIS from $255.00 to $265.00 and gave the stock an “overweight” rating in a research report on Tuesday, September 3rd. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $262.50.

STERIS Trading Down 1.0 %

NYSE STE opened at $214.22 on Monday. The stock has a market cap of $21.15 billion, a P/E ratio of 48.91 and a beta of 0.83. The company’s fifty day simple moving average is $220.80 and its 200-day simple moving average is $227.30. The company has a current ratio of 2.41, a quick ratio of 1.55 and a debt-to-equity ratio of 0.33. STERIS plc has a 52 week low of $197.82 and a 52 week high of $248.24.

STERIS (NYSE:STE) last issued its quarterly earnings data on Wednesday, November 6th. The medical equipment provider reported $2.14 EPS for the quarter, topping analysts’ consensus estimates of $2.12 by $0.02. The firm had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.33 billion. STERIS had a net margin of 8.02% and a return on equity of 13.78%. The firm’s revenue was up 7.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.03 EPS. Equities research analysts predict that STERIS plc will post 9.1 EPS for the current fiscal year.

STERIS Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Shareholders of record on Tuesday, November 19th will be paid a dividend of $0.57 per share. The ex-dividend date of this dividend is Tuesday, November 19th. This represents a $2.28 dividend on an annualized basis and a yield of 1.06%. STERIS’s dividend payout ratio (DPR) is presently 52.05%.

Insiders Place Their Bets

In other news, SVP Cary L. Majors sold 1,682 shares of the firm’s stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $217.32, for a total transaction of $365,532.24. Following the completion of the sale, the senior vice president now owns 11,372 shares of the company’s stock, valued at approximately $2,471,363.04. This trade represents a 12.88 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.14% of the stock is owned by company insiders.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.